STAT+: Bay Area biotech uses AI to unlock RNA structures — and find new therapies in the process
A new Bay Area biotech is harnessing artificial intelligence to better understand and predict RNA structures in hopes of developing new therapeutics.
News
Targeted cell control
A new method for prompting cells to create specific proteins can more accurately focus on which cells make the proteins and when. Given the diverse purposes of proteins in the body, this could lead to advances in medical treatments and research, among … […]
News
STAT+: Pharmalittle: FDA user-fee reauthorization bill hits a snag; USPTO takes a tougher stand toward drugmakers
People who work at biotechs, life sciences firms, and drugmakers pull in the largest salaries of anyone in health care — usually more than $100,000 per year. […]
News
STAT+: How one pharma insider sees the drug pricing reform law: the impact will ‘vary by product and by company’
A deep dive by one pharma insider on the implications of the new drug pricing reform law. […]
